People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Qlaris Bio, Inc. | — | Biotechnology | Series B | $37.8M | $22.4M | 2019 |
| Jade Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $1.4M | $1.1M | — |
Barbara Wirostko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barbara Wirostko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Dinesh Patel | 1 | 13 |
| Adrienne Graves | 1 | 6 |
| Ron Hunt | 1 | 4 |
| Ronald M. Hunt | 1 | 4 |
| Andrew Danielsen | 1 | 3 |
| Arthur Klausner | 1 | 2 |
| Wende M. Hutton | 1 | 2 |
| Thurein Htoo | 1 | 1 |
| Andrew Danielson | 1 | 1 |
| Randall Olson | 1 | 1 |
| Mary Jane Rafii | 1 | 1 |
| Barbara M. Wirostko | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.